ROBERTO ROMERO, MD
Medical Practice at John R, Detroit, MI
License number
Michigan 4301058903
Category
Medical Practice
Type
Maternal & Fetal Medicine
Address
Address
3980 John R St, Detroit, MI 48201
Phone
(888) 362-2500
(313) 993-2700
(313) 993-2700
Organization information
See more information about ROBERTO ROMERO at bizstanding.comPerinatology Research Branch - Roberto Romero MD
3990 John R St #4BRUSH, Detroit, MI 48201
Categories:
Gynecology & Obstetrics Physicians & Surgeons
Phone:
(313) 993-2700 (Phone)
Roberto Romero MD
4707 St Antoine St, Detroit, MI 48201
Industry:
Obgyn
Phone:
(313) 745-7555 (Phone)
Roberto J. Romero
Professional information
See more information about ROBERTO ROMERO at trustoria.com
Roberto J Romero, Detroit MI
Roberto J Romero, Detroit MI
Specialties:
Obstetrics & Gynecology, Maternal & Fetal Medicine
Work:
Wayne State Univ. School Of Medicine
4707 Saint Antoine St, Detroit, MI 48201
4707 Saint Antoine St, Detroit, MI 48201
Education:
Universidad Del Zulia (1974)
Dr. Roberto Romero, Detroit MI - MD (Doctor of Medicine)
Dr. Roberto Romero, Detroit MI - MD (Doctor of Medicine)
Specialties:
Maternal-Fetal Medicine
Address:
3990 John R St SUITE 4TH, Detroit 48201
(888) 362-2500 (Phone), (313) 745-0499 (Fax)
(888) 362-2500 (Phone), (313) 745-0499 (Fax)
Certifications:
Fetal Medicine & Maternal Medicine, 1987, Obstetrics & Gynecology, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3990 John R St SUITE 4TH, Detroit 48201
Hutzel Women's Hospital
3980 John R St, Detroit 48201
Hutzel Women's Hospital
3980 John R St, Detroit 48201
Education:
Medical School
University of Zulia / School of Medicine
Hosp Genl Del Sur
Yale New Haven Hospital
Yale University School Of Medicine
University of Zulia / School of Medicine
Hosp Genl Del Sur
Yale New Haven Hospital
Yale University School Of Medicine
Methods Of Determining Whether A Pregnant Woman Is At Risk Of Developing Preeclampsia
Methods Of Determining Whether A Pregnant Woman Is At Risk Of Developing Preeclampsia
US Patent:
7790463, Sep 7, 2010
Filed:
Feb 2, 2006
Appl. No.:
11/346694
Inventors:
Gil G. Mor - Cheshire CT, US
Donna Neale - New Haven CT, US
Roberto Romero - Grosse Pointe MI, US
Donna Neale - New Haven CT, US
Roberto Romero - Grosse Pointe MI, US
Assignee:
Yale University - New Haven CT
The United States of America as represented by the Department of Health and Human Services - Washington DC
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
G01N 33/48, C07K 1/00
US Classification:
436 65, 530351
Abstract:
The present invention provides methods and compositions related to biomarker profiles for each trimester of pregnancy. The present invention also provides methods for identifying patients at risk of developing a complication of pregnancy, such as preeclampsia. In further embodiments, the present invention relates to methods for the diagnosis of patients with preeclampsia.
Branch Chief At Nichd - Nih/Dhhs
Branch Chief At Nichd - Nih/Dhhs
Position:
Branch Chief at NICHD - NIH/DHHS
Location:
Greater Detroit Area
Industry:
Research
Work:
NICHD - NIH/DHHS
-
Branch Chief
Methods And Kits For Determining Risk Of Pre-Term Delivery
Methods And Kits For Determining Risk Of Pre-Term Delivery
US Patent:
2004024, Dec 2, 2004
Filed:
Nov 13, 2003
Appl. No.:
10/713791
Inventors:
Roberto Romero - Detroit MI, US
Irina Buhimschi - New Haven CT, US
Robert Christner - Albuquerque NM, US
Irina Buhimschi - New Haven CT, US
Robert Christner - Albuquerque NM, US
Assignee:
The Govt. of the USA as represented by the Secretary of the Dept. of Health & Human Services
International Classification:
G01N033/53, G01N033/537, G01N033/543
US Classification:
435/007920
Abstract:
Biomarkers capable of identifying subjects at risk for preterm complications, such as preterm parturition are disclosed, as well as methods and kits for detecting such biomarkers to identify at risk subjects. A single biomarker or combination of biomarkers comprising a defensin, BPI, calprotectin, or a calgranulin are used to qualify the risk of preterm complications in a subject. In particular, the concentrations of the biomarkers correlate with the magnitude of preterm complications and can diagnose or prognose specific preterm complications, such as preterm parturition, preterm premature rupture of the membranes (PROM), intra-amniotic inflammation, and/or microbial invasion of the amniotic cavity (MIAC).
In Vitro Test To Detect Risk Of Preeclampsia
In Vitro Test To Detect Risk Of Preeclampsia
US Patent:
7541182, Jun 2, 2009
Filed:
Feb 13, 2004
Appl. No.:
10/779360
Inventors:
Gil G. Mor - Cheshire CT, US
Donna Neale - New Haven CT, US
Roberto Romero - Grosse Pointe Farms MI, US
Donna Neale - New Haven CT, US
Roberto Romero - Grosse Pointe Farms MI, US
Assignee:
Yale University - New Haven CT
The United States of America as represented by the Department of Health and Human Services - Washington DC
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 5/08
US Classification:
435372
Abstract:
The present invention provides methods for identifying patients at risk of developing preeclampsia. In further embodiments, the present invention relates to methods for the diagnosis of patients with preeclampsia.
Branch Chief At Nichd - Nih/Dhhs
Branch Chief At Nichd - Nih/Dhhs
Position:
Branch Chief at NICHD - NIH/DHHS
Location:
Greater Detroit Area
Industry:
Research
Work:
NICHD - NIH/DHHS
-
Branch Chief